1.
Clin Infect Dis
; 72(7): 1247-1250, 2021 04 08.
Article
in English
| MEDLINE | ID: covidwho-1174886
ABSTRACT
Hyperinflammation is associated with increased mortality in coronavirus disease 2019 (COVID-19). In this retrospective, uncontrolled patient cohort with moderate -severe COVID-19, treatment with baricitinib plus hydroxychloroquine was associated with recovery in 11 of 15 patients. Baricitinib for the treatment of COVID-19 should be further investigated in randomized, controlled clinical trials.